Alzheimer Disease
Copyright © 2018 Elsevier Inc. All rights reserved..
Alzheimer disease is due to increased amyloid-β coupled with low progranulin. Several brain imaging techniques are helpful in the diagnosis. Drugs available for treating Alzheimer disease have limited clinical utility. Cognitive stimulation therapy is an effective therapy for persons with moderate Alzheimer disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Clinics in geriatric medicine - 34(2018), 4 vom: 17. Nov., Seite 591-601 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Morley, John E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Amyloid beta-Peptides |
|---|
| Anmerkungen: |
Date Completed 18.04.2019 Date Revised 18.04.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cger.2018.06.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM289715059 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM289715059 | ||
| 003 | DE-627 | ||
| 005 | 20231225063147.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cger.2018.06.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0965.xml |
| 035 | |a (DE-627)NLM289715059 | ||
| 035 | |a (NLM)30336989 | ||
| 035 | |a (PII)S0749-0690(18)30999-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Morley, John E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Alzheimer Disease |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.04.2019 | ||
| 500 | |a Date Revised 18.04.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2018 Elsevier Inc. All rights reserved. | ||
| 520 | |a Alzheimer disease is due to increased amyloid-β coupled with low progranulin. Several brain imaging techniques are helpful in the diagnosis. Drugs available for treating Alzheimer disease have limited clinical utility. Cognitive stimulation therapy is an effective therapy for persons with moderate Alzheimer disease | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Amyloid-β | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Cognitive stimulation therapy | |
| 650 | 4 | |a Olive oil | |
| 650 | 4 | |a Progranulin | |
| 650 | 4 | |a SAMP8 | |
| 650 | 7 | |a Amyloid beta-Peptides |2 NLM | |
| 650 | 7 | |a Progranulins |2 NLM | |
| 700 | 1 | |a Farr, Susan A |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Andrew D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinics in geriatric medicine |d 1996 |g 34(2018), 4 vom: 17. Nov., Seite 591-601 |w (DE-627)NLM013115219 |x 1879-8853 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2018 |g number:4 |g day:17 |g month:11 |g pages:591-601 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cger.2018.06.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2018 |e 4 |b 17 |c 11 |h 591-601 | ||